Growth Metrics

Myriad Genetics (MYGN) Change in Acquisitions & Divestments (2016 - 2024)

Myriad Genetics has reported Change in Acquisitions & Divestments over the past 16 years, most recently at $5.0 million for Q3 2024.

  • Quarterly Change in Acquisitions & Divestments fell 66.67% to $5.0 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Jun 2025, down 75.61% year-over-year, with the annual reading at $9.0 million for FY2024, 91.44% down from the prior year.
  • Change in Acquisitions & Divestments was $5.0 million for Q3 2024 at Myriad Genetics, up from $2.5 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $58.1 million in Q1 2023 and troughed at $1.5 million in Q4 2023.
  • The 5-year median for Change in Acquisitions & Divestments is $18.6 million (2020), against an average of $21.7 million.
  • Year-over-year, Change in Acquisitions & Divestments soared 318.9% in 2020 and then crashed 97.42% in 2024.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $35.9 million in 2020, then plummeted by 32.31% to $24.3 million in 2021, then surged by 67.08% to $40.6 million in 2022, then tumbled by 96.31% to $1.5 million in 2023, then surged by 233.33% to $5.0 million in 2024.
  • Per Business Quant, the three most recent readings for MYGN's Change in Acquisitions & Divestments are $5.0 million (Q3 2024), $2.5 million (Q2 2024), and $1.5 million (Q1 2024).